Search

everythinglearnresearchcommunity

for

Search:↓

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

New hair can grow from large wounds in mice, but less so as they age, involving reprogramming of skin cells and specific molecular pathways.

PDCD4 is important for controlling skin cell growth and healing.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Using skin stem cells and certain molecules might lead to scar-free skin healing.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Skin cell-derived vesicles can help heal skin injuries effectively.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Iron deficiency might contribute to hair loss in women.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

Spin traps like PBN could protect skin from pollution and sunlight in cosmetics but need more research for safe use.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

SesZen-Bio™ improves hair density, thickness, and overall hair health.